Disposition of [14C]nadolol in dogs with reversible renal impairment induced by uranyl nitrate.
D000319:Adrenergic beta-Antagonists / Q000378:metabolism*; D000818:Animals; D001711:Biotransformation; D004285:Dogs; D005919:Glomerular Filtration Rate / Q000187:drug effects; D007674:Kidney Diseases / Q000139:chemically induced / Q000378:metabolism*; D007700:Kinetics; D008297:Male; D011412:Propanolamines / Q000378:metabolism*; D014501:Uranium / Q000494:pharmacology*; D014502:Uranyl Nitrate / Q000494:pharmacology*
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; D014502:Uranyl Nitrate; D014501:Uranium